Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.08. | Basilea Pharmaceutica - Poised for an eventful H224 | 347 | Edison Investment Research | Basilea's H124 results reflect strong momentum across its pipeline and we expect the pace to accelerate in H224. The key highlight of the period was the FDA approval of Zevtera. We now expect all eyes... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 2.854 |
EVOTEC | 2.060 |
TUI | 1.745 |
BAYER | 1.696 |
NVIDIA | 1.605 |
NEL | 1.174 |
RENK GROUP | 1.081 |
RHEINMETALL | 997 |
TESLA | 839 |
PALANTIR TECHNOLOGIES | 790 |
DEUTSCHE BANK | 734 |
VOLKSWAGEN | 715 |
MICROSTRATEGY | 684 |
BYD | 660 |
PLUG POWER | 651 |
COMMERZBANK | 605 |
BASF | 595 |
JINKOSOLAR | 595 |
MERCEDES-BENZ | 571 |
AMAZON | 551 |
INTEL | 533 |
BMW | 526 |
DEUTSCHE TELEKOM | 523 |
HUGO BOSS | 522 |
THYSSENKRUPP | 509 |